Management of Resistant Hypertension in Elderly Patients

Introduction to Resistant Hypertension Management

The American Heart Association recommends adding a thiazide-like diuretic, such as chlorthalidone 12.5-25 mg daily or indapamide 1.25-2.5 mg daily, as the fourth antihypertensive agent to achieve guideline-recommended therapy for resistant hypertension, with the goal of reducing blood pressure to target levels 1, 2
The International Society of Hypertension guidelines explicitly recommend the sequence: ACE inhibitor → add CCB → add thiazide/thiazide-like diuretic → then consider spironolactone or other fourth-line agents, for patients with resistant hypertension 1, 2

Resistant hypertension is defined as blood pressure remaining elevated (≥180/90 mmHg) despite adherence to three antihypertensive agents at appropriate doses, including a diuretic, with the patient's current regimen including amlodipine 10 mg, bisoprolol 5 mg, and lisinopril 40 mg 1, 2
The blood pressure of 180/90 mmHg represents stage 2 hypertension with >40 mmHg elevation above target, requiring immediate treatment intensification rather than observation, in a patient with no compelling indications for beta-blocker use 1, 2

Thiazide-like diuretics (chlorthalidone or indapamide) are preferred over traditional hydrochlorothiazide due to longer duration of action and superior evidence for cardiovascular outcomes, with a recommended starting dose of 12.5-25 mg daily for chlorthalidone or 1.25-2.5 mg daily for indapamide 2, 3
The current regimen is non-standard because it includes a beta-blocker (bisoprolol) instead of following the guideline-recommended triple therapy sequence of ACE inhibitor + calcium channel blocker + thiazide diuretic, with the American College of Cardiology recommending against the use of beta-blockers as first-line therapy for hypertension in the absence of compelling indications 1, 2

Check serum potassium and creatinine 1-2 weeks after initiating diuretic therapy to detect hypokalemia, hyponatremia, or changes in renal function, with the patient's renal function and electrolyte levels being closely monitored 2, 3
Reassess blood pressure within 2-4 weeks after adding the diuretic, with the goal of achieving target BP within 3 months of treatment modification, and adjust the treatment plan as needed to achieve optimal blood pressure control 1, 2

Target BP <140/90 mmHg minimum for this elderly patient, though <130/80 mmHg may be appropriate if well-tolerated and no frailty concerns, with the American Heart Association recommending individualized blood pressure targets based on patient characteristics and comorbidities 1, 2
For elderly patients, individualize targets based on frailty status—frailer patients may benefit from less aggressive targets to avoid orthostatic hypotension and falls, with the patient's frailty status and risk of orthostatic hypotension being taken into account when determining the target blood pressure 1

Sodium restriction to <2 g/day can provide additive BP reduction of 5-10 mmHg, with the patient being advised to follow a low-sodium diet to help achieve optimal blood pressure control 2, 3
Weight management (target BMI 20-25 kg/m²), regular aerobic exercise (150 minutes/week), and alcohol limitation (<100 g/week) provide cumulative BP reductions of 10-20 mmHg, with the patient being encouraged to adopt a healthy lifestyle to help manage their blood pressure 2